You are here

  • Home
  • Archive
  • Volume 83, Issue 3
  • 148 The effect of natalizumab and interferon-β on urinary free light chains and anti-EBV nuclear antigen-1 antibodies in relapsing remitting multiple sclerosis

Alerts

Article menu
Download PDFPDF
ABN abstracts
Abstracts from the Association of British Neurologists Annual Meeting 2011
148 The effect of natalizumab and interferon-β on urinary free light chains and anti-EBV nuclear antigen-1 antibodies in relapsing remitting multiple sclerosis
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address